Kamada (KMDA) Net Income (QoQ) (2013 - 2026)
Kamada (KMDA) Net Income (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Kamada | 402.37 Mn | 329.22 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.00% |
| Dec 31, 2025 | -32.74% |
| Sep 30, 2025 | -28.20% |
| Jun 30, 2025 | 86.07% |
| Mar 31, 2025 | 4.10% |
| Dec 31, 2024 | -1.42% |
| Sep 30, 2024 | -12.72% |
| Jun 30, 2024 | 87.15% |
| Mar 31, 2024 | -53.24% |
| Dec 31, 2023 | 56.93% |
| Sep 30, 2023 | 77.87% |
| Jun 30, 2023 | 100,065.84% |
| Mar 31, 2023 | -38.55% |
| Dec 31, 2022 | 508.26% |
| Sep 30, 2022 | -99.99% |
| Jun 30, 2022 | 114.50% |
| Mar 31, 2022 | 36,394.31% |
| Dec 31, 2021 | -99.41% |
| Sep 30, 2021 | -9.82% |
| Jun 30, 2021 | -65.13% |